HepaRegeniX GmbH
PrivateLast Round
Series C
Apr 15, 2025
Total Funding Raised
$46.09M
Company Overview
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HepaRegeniX GmbH Comps
Public and private peers based on sector, stage, and business model.
HepaRegeniX GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2025 | ||||
| Series B | Jan 21, 2020 | ||||
| Series A | Jan 5, 2017 |
Key People
Founding team and executive leadership
HepaRegeniX GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vesalius Biocapital IV | Series C |
| Novo Seeds | Series A |
| Boehringer Ingelheim Venture Fund | Series C |
| Ascenion | Series C |
| Novo Holdings | Series B, Series C |
| Boehringer Ingelheim Venture Fund | Series B, Series C, Series A |
| Wellington Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2025
HRX-233 targets kinase inhibitor resistance in KRAS-driven tumours.
- May 8, 2025
Presented development updates and clinical data for HRX-215 at EASL Congress 2025.
HepaRegeniX GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HepaRegeniX GmbH's valuation, stock price, and market status.
